Activity of antioxidant enzymes in children from families at high risk of premature coronary heart disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 2, 2003, Pages 151-158

  Siemianowicz, Krzysztof ^a   Gminski J ^a   Francuz, T ^a   Wojcik A ^a   Posielezna B ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antioxidant enzymes; Children; Family history of CHD

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME ACTIVITY; ERYTHROCYTE; FAMILY HISTORY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NORMAL HUMAN; OBESITY; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

FELIS CATUS;

EID: 0038216573     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310002013-1     Document Type: Article

References (36)

1. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Cirulation 1999; 100: 1481-92.
2. Pyörälä K, de Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994; 110: 121-61.
3. Grundy SM. United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy. Am J Cardiol 2001; 88: 23J-7J.
4. Sholtz RI, Rosenman RH, Brand RJ. The relationship of reported parental history to the incidence of coronary heart disease in the Western Collaborative Group Study. Am J Epidemiol 1975; 102: 350-6.
5. Friedlander Y, Kark JD, Stein Y. Family history of myocardial infarction as an independent risk factor for coronary heart disease. Br Heart J 1985; 53: 382-7.
6. Assmann G, Schulte H. Identification of individuals at high risk for myocardial infarction. Atherosclerosis 1994; 110: S11-21.
7. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980; 61: 503-9.
8. Raiwater DL, McMaham AC, Malcolm GT, Scheer WD, Roheim PS, McGill HC, Strong JP. Lipid and apolipoprotein predictors of atherosclerosis in youth. Atherioscler Thromb Vasc Biol 1999; 19: 753-61.
9. Shah PK. Circulating markers of inflammation for vascular risk prediction. Are they ready for prime time? Circulation 2000; 101: 1758.
10. Libby P, Ridker P. Novel inflammatory markers of coronary risk. Theory versus practice. Circulation 1999; 100: 1148-50.
11. Grundy SM. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation 1999; 100: 988-98.
12. Kuller LH. Clinical trials: surrogate endpoints on hard endpoints? Am J Cardiol 2001; 88: 59E-61E.
13. Ballantyne CM. Surrogate endpoints and newer risk markers in atherosclerosis management. Am J Manag Care 2001; 7: S144-7.
14. Gmiński J, Dróżdż M, Ulfig-Maślanka R, Najda J. Evaluation of elastin metabolsim in children from families with high risk of atherosclerosis. Atherosclerosis 1991; 91: 185-9.
15. Wojakowski W, Gmiński J. Serum levels of soluble ICAM-1, VCAM-1 and E-elastin in children from families with high risk of atherosclerosis. Int J Mol Med 2001; 7: 181-5.
16. Wojakowski W, Gmiński J. Plasma level of von Willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease. Scand J Clin Lab Invest 2001; 61: 317-24.
17. Mashima R, Witting PK, Stocker R. Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol 2001; 12: 411-8.
18. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherosclerosis: an overview. Free Radic Biol Med 2000; 28: 1815-26.
19. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
20. Szamosi T, Mihai K, Peto J, Makary A, Kramer J. Potential markers of the atherosclerotic process in high-risk children. Clin Biochem 1991; 24: 185-7.
21. Blann AD, Maxwell SR, Burrows G, Miller JP. Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolemia and vascular disease. Atherosclerosis 1995; 116: 191-8.
22. Guidi G, Schiavon R, Sheiban I, Perona G. Platelet glutathione peroxidase activity is impaired in patients with coronary heart disease. Scand J Clin Invest 1986; 46: 549-51.
23. Buczyński A, Wachowicz B, Kȩdziora-Kornatowska K, Tkaczewski W, Kȩdziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993; 100: 223-8.
24. Morrison JA, Jacobsen DW, Sprecher DL, Robinson K, Khoury P, Daniels SR. Serum glutathione in adolescent males predicts parental coronary disease. Circulation 1999; 100: 2244-7.
25. Takeshita S, Inoue N, Ueyama T, Kawashima S, Yokoyama M. Shear stress enhances glutathione peroxidase expression in endothelial cells. Biochem Biophys Res Commun 2000; 273: 66-71.
26. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000; 2: 98-105.
27. Meilhac O, Zhou M, Santanam N, Parthasarathy S. Lipid peroxides induce expression of catalase in cultured vascular cells. J Lipid Res 2000; 41: 1205-13.
28. Santanam N, Aug N, Zhou M, Keshava C, Parthasarathy S. Overexpression of human catalase gene decreases oxidased lipid-induced cytotoxicity in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1912-7.
29. Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Ucchino S, Calafiore AM, Napolitano AM, Di Ilio C, Cuccurullo F. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998; 97: 1930-4.
30. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175-83.
31. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73.
32. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001; 53: 33-9.
33. Bełtowski J, Wójcicka G, Górny D, Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 2000; 51: 883-96.
34. Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta 2001; 305: 75-80.
35. Guemouri L, Artur Y, Herberth B, Jeandel C, Cuny G, Siest G. Biological variability of super-oxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 37: 1932-7.
36. Bolzan AD, Bianchi MS, Bianchi NO. Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking. Clin Biochem 1997; 30: 449-54.